
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $131.8M | $201.1M | $289.4M | $403.1M | $492.1M | |
Revenue Growth (YoY) | 38.84% | 52.64% | 43.86% | 39.3% | 22.09% | |
Cost of Revenues | $47.8M | $70.2M | $107.9M | $147.3M | $177.5M | |
Gross Profit | $84M | $131M | $181.4M | $255.8M | $314.7M | |
Gross Profit Margin | 63.73% | 65.11% | 62.7% | 63.45% | 63.94% | |
R&D Expenses | $24.5M | $31.3M | $50.3M | $62M | $66.6M | |
Selling, General & Admin | $75.3M | $112.9M | $161.4M | $215.2M | $255.3M | |
Other Inc / (Exp) | $72K | -$10.6M | -$9.2M | $4.2M | -$11.8M | |
Operating Expenses | $99.8M | $144.2M | $211.7M | $277.3M | $321.9M | |
Operating Income | -$15.8M | -$13.3M | -$30.2M | -$21.5M | -$7.3M | |
Net Interest Expenses | $2.5M | $2M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$18.3M | -$25.9M | -$37.4M | -$4.4M | $1.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$7.2M | $2.2M | $2M | $4.2M | -$1M | |
Net Income to Company | -$11.1M | -$28.1M | -$39.3M | -$8.6M | $2.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$11.1M | -$28.1M | -$39.3M | -$8.6M | $2.9M | |
Basic EPS (Cont. Ops) | -$0.12 | -$0.39 | -$0.36 | -$0.07 | $0.02 | |
Diluted EPS (Cont. Ops) | -$0.12 | -$0.39 | -$0.36 | -$0.07 | $0.02 | |
Weighted Average Basic Share | $89.1M | $71.2M | $107.9M | $114.8M | $124.3M | |
Weighted Average Diluted Share | $89.1M | $71.2M | $107.9M | $114.8M | $129.3M | |
EBITDA | -$8.9M | -$14.9M | -$23.8M | $11.8M | $19.8M | |
EBIT | -$15.7M | -$23.9M | -$36.1M | -$4M | $2.4M | |
Revenue (Reported) | $131.8M | $201.1M | $289.4M | $403.1M | $492.1M | |
Operating Income (Reported) | -$15.8M | -$13.3M | -$30.2M | -$21.5M | -$7.3M | |
Operating Income (Adjusted) | -$15.7M | -$23.9M | -$36.1M | -$4M | $2.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $45M | $64.6M | $94.4M | $114.1M | $133.5M | |
Revenue Growth (YoY) | 37.55% | 43.48% | 46.17% | 20.93% | 16.96% | |
Cost of Revenues | $16.1M | $24.3M | $33.9M | $71.2M | $81M | |
Gross Profit | $28.9M | $40.3M | $60.5M | $43M | $52.5M | |
Gross Profit Margin | 64.24% | 62.43% | 64.12% | 37.64% | 39.33% | |
R&D Expenses | $7.5M | $11M | $14.5M | $16.7M | $16.9M | |
Selling, General & Admin | $27.8M | $36.4M | $52.5M | $29.8M | $33.5M | |
Other Inc / (Exp) | -$1.4M | -$2.3M | $1.5M | -$4.9M | -$6.3M | |
Operating Expenses | $35.4M | $47.4M | $67.1M | $48.4M | $53.4M | |
Operating Income | -$6.5M | -$7.1M | -$6.6M | -$5.5M | -$949K | |
Net Interest Expenses | $621K | $218K | -- | -- | -- | |
EBT. Incl. Unusual Items | -$8.5M | -$9.6M | -$3.3M | -$4.6M | -$5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $199K | $500K | $417K | $1.6M | -$884K | |
Net Income to Company | -$8.7M | -$10.1M | -$3.7M | -$6.2M | -$4.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$8.7M | -$10.1M | -$3.7M | -$6.2M | -$4.2M | |
Basic EPS (Cont. Ops) | -$0.09 | -$0.10 | -$0.03 | -$0.05 | -$0.03 | |
Diluted EPS (Cont. Ops) | -$0.09 | -$0.10 | -$0.03 | -$0.05 | -$0.03 | |
Weighted Average Basic Share | $99.8M | $106.7M | $109.8M | $123.1M | $123.2M | |
Weighted Average Diluted Share | $99.8M | $106.7M | $109.8M | $123.1M | $123.2M | |
EBITDA | -$5.7M | -$6.6M | $568K | -$201K | $1.2M | |
EBIT | -$7.8M | -$9.4M | -$3.2M | -$4.5M | -$4.3M | |
Revenue (Reported) | $45M | $64.6M | $94.4M | $114.1M | $133.5M | |
Operating Income (Reported) | -$6.5M | -$7.1M | -$6.6M | -$5.5M | -$949K | |
Operating Income (Adjusted) | -$7.8M | -$9.4M | -$3.2M | -$4.5M | -$4.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $144.1M | $220.7M | $319.2M | $422.8M | $511.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $52.3M | $78.4M | $117.5M | $184.6M | $216.8M | |
Gross Profit | $91.8M | $142.4M | $201.6M | $238.2M | $294.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $26.7M | $34.7M | $53.8M | $64.2M | $66.8M | |
Selling, General & Admin | $84.3M | $121.5M | $177.5M | $192.5M | $227.1M | |
Other Inc / (Exp) | -$999K | -$11.6M | -$5.4M | -$2.2M | -$13.7M | |
Operating Expenses | $111M | $156.3M | $231.3M | $258.6M | $296.9M | |
Operating Income | -$19.2M | -$13.9M | -$29.7M | -$20.4M | -$2.2M | |
Net Interest Expenses | $2.6M | $1.6M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$22.7M | -$27.1M | -$31M | -$5.7M | $1.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $711K | $2.5M | $1.9M | $5.4M | -$3.5M | |
Net Income to Company | -$23.5M | -$29.6M | -$32.9M | -$11.1M | $5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$23.5M | -$29.6M | -$32.9M | -$11.1M | $5M | |
Basic EPS (Cont. Ops) | -$0.25 | -$0.46 | -$0.30 | -$0.09 | $0.04 | |
Diluted EPS (Cont. Ops) | -$0.25 | -$0.48 | -$0.30 | -$0.10 | $0.03 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$12.8M | -$15.8M | -$16.7M | $11M | $21.1M | |
EBIT | -$20.2M | -$25.5M | -$29.9M | -$5.3M | $2.5M | |
Revenue (Reported) | $144.1M | $220.7M | $319.2M | $422.8M | $511.5M | |
Operating Income (Reported) | -$19.2M | -$13.9M | -$29.7M | -$20.4M | -$2.2M | |
Operating Income (Adjusted) | -$20.2M | -$25.5M | -$29.9M | -$5.3M | $2.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $45M | $64.6M | $94.4M | $114.1M | $133.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $16.1M | $24.3M | $33.9M | $71.2M | $81M | |
Gross Profit | $28.9M | $40.3M | $60.5M | $43M | $52.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $7.5M | $11M | $14.5M | $16.7M | $16.9M | |
Selling, General & Admin | $27.8M | $36.4M | $52.5M | $29.8M | $33.5M | |
Other Inc / (Exp) | -$1.4M | -$2.3M | $1.5M | -$4.9M | -$6.3M | |
Operating Expenses | $35.4M | $47.4M | $67.1M | $48.4M | $53.4M | |
Operating Income | -$6.5M | -$7.1M | -$6.6M | -$5.5M | -$949K | |
Net Interest Expenses | $621K | $218K | -- | -- | -- | |
EBT. Incl. Unusual Items | -$8.5M | -$9.6M | -$3.3M | -$4.6M | -$5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $199K | $500K | $417K | $1.6M | -$884K | |
Net Income to Company | -$8.7M | -$10.1M | -$3.7M | -$6.2M | -$4.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$8.7M | -$10.1M | -$3.7M | -$6.2M | -$4.2M | |
Basic EPS (Cont. Ops) | -$0.09 | -$0.10 | -$0.03 | -$0.05 | -$0.03 | |
Diluted EPS (Cont. Ops) | -$0.09 | -$0.10 | -$0.03 | -$0.05 | -$0.03 | |
Weighted Average Basic Share | $99.8M | $106.7M | $109.8M | $123.1M | $123.2M | |
Weighted Average Diluted Share | $99.8M | $106.7M | $109.8M | $123.1M | $123.2M | |
EBITDA | -$5.7M | -$6.6M | $568K | -$201K | $1.2M | |
EBIT | -$7.8M | -$9.4M | -$3.2M | -$4.5M | -$4.3M | |
Revenue (Reported) | $45M | $64.6M | $94.4M | $114.1M | $133.5M | |
Operating Income (Reported) | -$6.5M | -$7.1M | -$6.6M | -$5.5M | -$949K | |
Operating Income (Adjusted) | -$7.8M | -$9.4M | -$3.2M | -$4.5M | -$4.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $104.1M | $385.4M | $349.2M | $654.6M | $495.2M | |
Short Term Investments | -- | -- | -- | -- | $115.8M | |
Accounts Receivable, Net | $11.6M | $13M | $13.7M | $18.2M | $23.7M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $3.8M | $9.8M | $17.5M | $18.2M | $22.5M | |
Total Current Assets | $148.6M | $443.8M | $450.6M | $815.7M | $762.9M | |
Property Plant And Equipment | $5.1M | $9.4M | $13.3M | $15.1M | $17.2M | |
Long-Term Investments | -- | -- | -- | -- | $50.1M | |
Goodwill | $44.7M | $85.8M | $97.8M | $121.6M | $149.6M | |
Other Intangibles | $68.2M | $93.6M | $97.6M | $108.2M | $118.7M | |
Other Long-Term Assets | $4.9M | $7.2M | $14.9M | $19.1M | $24M | |
Total Assets | $271.4M | $639.8M | $674.3M | $1.1B | $1.1B | |
Accounts Payable | $5.4M | $10.2M | $13.3M | $12.6M | $15.4M | |
Accrued Expenses | $4.6M | $6.2M | $10.7M | $15.8M | $20.9M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | $1.8M | $1.5M | $1.7M | |
Other Current Liabilities | $6.7M | $7.7M | -- | $2.1M | $4.1M | |
Total Current Liabilities | $88.4M | $117.5M | $177.3M | $273.8M | $289.8M | |
Long-Term Debt | $24.4M | $25.9M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $353.2M | $157.6M | $192.4M | $293.6M | $307.7M | |
Common Stock | $2K | $11K | $11K | $12K | $13K | |
Other Common Equity Adj | -- | -$399K | -$1.9M | $1.3M | -$2.1M | |
Common Equity | -$81.8M | $482.2M | $481.9M | $786.1M | $814.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$81.8M | $482.2M | $481.9M | $786.1M | $814.8M | |
Total Liabilities and Equity | $271.4M | $639.8M | $674.3M | $1.1B | $1.1B | |
Cash and Short Terms | $104.1M | $385.4M | $349.2M | $654.6M | $611.1M | |
Total Debt | $24.4M | $25.9M | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $146.3M | $365.7M | $327.1M | $619M | $190.5M | |
Short Term Investments | -- | -- | -- | -- | $64.8M | |
Accounts Receivable, Net | $11.5M | $13.8M | $17.9M | $19.7M | $33.6M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $6.8M | $8.7M | $16.2M | $16.2M | $31.9M | |
Total Current Assets | $179.4M | $413.6M | $395.9M | $739.2M | $396.5M | |
Property Plant And Equipment | $6.1M | $10.1M | $14.3M | $15.6M | $17.4M | |
Long-Term Investments | -- | -- | -- | -- | $18.1M | |
Goodwill | $44.6M | $84.7M | $98.3M | $119.7M | $402.7M | |
Other Intangibles | $66.6M | $90.5M | $95.1M | $103.4M | $202M | |
Other Long-Term Assets | $5.7M | $10.6M | $17.4M | $20.8M | $23.6M | |
Total Assets | $302.3M | $609.5M | $621M | $998.7M | $1.1B | |
Accounts Payable | $9.1M | $8.8M | $14.2M | $15.4M | $15.1M | |
Accrued Expenses | $6M | $8M | $11.6M | $13.1M | $22.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | $1.7M | $1.8M | $1.4M | $1.6M | |
Other Current Liabilities | $5.5M | $656K | $21K | -- | -- | |
Total Current Liabilities | $59.9M | $91.2M | $116.3M | $182.5M | $195.9M | |
Long-Term Debt | $24.4M | $25.9M | -- | -- | $60M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $379.6M | $131.4M | $130.8M | $201.7M | $276.1M | |
Common Stock | $3K | $11K | $11K | $12K | $13K | |
Other Common Equity Adj | -- | -- | -$2.3M | -$41K | $482K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | $59.7M | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$77.3M | $478.1M | $490.2M | $797M | $784.3M | |
Total Liabilities and Equity | $302.3M | $609.5M | $621M | $998.7M | $1.1B | |
Cash and Short Terms | $146.3M | $365.7M | $327.1M | $619M | $255.3M | |
Total Debt | $24.4M | $25.9M | -- | -- | $60M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$11.1M | -$28.1M | -$39.3M | -$8.6M | $2.9M | |
Depreciation & Amoritzation | $6.8M | $9M | $12.3M | $15.8M | $17.4M | |
Stock-Based Compensation | $3.8M | $18.9M | $30.3M | $43.7M | $64.9M | |
Change in Accounts Receivable | -$8M | -$8M | -$33.2M | -$58.5M | $13.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$14.2M | $17.1M | $5.4M | $80.6M | $91.5M | |
Capital Expenditures | $2.1M | $6.7M | $7.1M | $6M | $6.2M | |
Cash Acquisitions | -$79.4M | -$56.1M | -$17.6M | -$32.8M | -$45.2M | |
Cash From Investing | -$81.5M | -$62.9M | -$24.7M | -$38.8M | -$215.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $4.2M | $25.9M | -- | -- | -- | |
Long-Term Debt Repaid | -$4.2M | -$25M | -$25.9M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -$43.7M | |
Other Financing Activities | -$1.5M | -$9.1M | -$6.3M | -$10.8M | -$2.6M | |
Cash From Financing | $119M | $327.5M | -$24M | $263.4M | -$37.6M | |
Beginning Cash (CF) | $86M | $109.1M | $389.4M | $351.2M | $654.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $23.3M | $281.7M | -$43.2M | $305.3M | -$162M | |
Ending Cash (CF) | $109.1M | $389.4M | $351.2M | $654.6M | $495.2M | |
Levered Free Cash Flow | -$16.4M | $10.4M | -$1.6M | $74.6M | $85.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$8.7M | -$10.1M | -$3.7M | -$6.2M | -$4.2M | |
Depreciation & Amoritzation | $2.1M | $2.8M | $3.7M | $4.3M | $5.5M | |
Stock-Based Compensation | $10.4M | $5.5M | $8.6M | $14.8M | $18.2M | |
Change in Accounts Receivable | $14.4M | $9.4M | $31.2M | $39M | $26.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$14.8M | -$17M | -$20.8M | -$38.1M | -$78.9M | |
Capital Expenditures | $1.5M | $1.3M | $1.8M | $1.5M | $1.5M | |
Cash Acquisitions | -- | -- | -- | -- | -$319.8M | |
Cash From Investing | -$1.5M | -$1.3M | -$1.8M | -$1.5M | -$237.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $125M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$65M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$49.3M | |
Other Financing Activities | -$4M | -$4.1M | -$1.2M | -$783K | -$1.7M | |
Cash From Financing | $58.2M | -$3M | $1.8M | $2.2M | $11.6M | |
Beginning Cash (CF) | $109.1M | $389.4M | $351.2M | $654.6M | $495.2M | |
Foreign Exchange Rate Adjustment | $348K | $1.7M | -$1.2M | $1.8M | $388K | |
Additions / Reductions | $41.9M | -$21.3M | -$20.9M | -$37.4M | -$305.1M | |
Ending Cash (CF) | $151.3M | $369.7M | $329.1M | $619M | $190.5M | |
Levered Free Cash Flow | -$16.3M | -$18.3M | -$22.7M | -$39.6M | -$80.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$23.5M | -$29.6M | -$32.9M | -$11.1M | $5M | |
Depreciation & Amoritzation | $7.4M | $9.7M | $13.2M | $16.3M | $18.6M | |
Stock-Based Compensation | $13.4M | $14.1M | $33.4M | $50M | $68.3M | |
Change in Accounts Receivable | -$2.6M | -$13M | -$11.3M | -$50.7M | $1.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $18.1M | $14.9M | $1.6M | $63.4M | $50.7M | |
Capital Expenditures | $3.1M | $6.5M | $7.6M | $5.7M | $6.2M | |
Cash Acquisitions | -- | -$56.1M | -$17.6M | -$32.8M | -$365.1M | |
Cash From Investing | -$3.1M | -$62.7M | -$25.2M | -$38.4M | -$452.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$4.1M | -$9.2M | -$3.4M | -$10.3M | -$3.5M | |
Cash From Financing | $60.4M | $266.3M | -$19.2M | $263.9M | -$28.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $75.4M | $218.5M | -$42.8M | $288.8M | -$429.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $15M | $8.4M | -$6M | $57.7M | $44.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$8.7M | -$10.1M | -$3.7M | -$6.2M | -$4.2M | |
Depreciation & Amoritzation | $2.1M | $2.8M | $3.7M | $4.3M | $5.5M | |
Stock-Based Compensation | $10.4M | $5.5M | $8.6M | $14.8M | $18.2M | |
Change in Accounts Receivable | $14.4M | $9.4M | $31.2M | $39M | $26.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$14.8M | -$17M | -$20.8M | -$38.1M | -$78.9M | |
Capital Expenditures | $1.5M | $1.3M | $1.8M | $1.5M | $1.5M | |
Cash Acquisitions | -- | -- | -- | -- | -$319.8M | |
Cash From Investing | -$1.5M | -$1.3M | -$1.8M | -$1.5M | -$237.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $125M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$65M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$49.3M | |
Other Financing Activities | -$4M | -$4.1M | -$1.2M | -$783K | -$1.7M | |
Cash From Financing | $58.2M | -$3M | $1.8M | $2.2M | $11.6M | |
Beginning Cash (CF) | $109.1M | $389.4M | $351.2M | $654.6M | $495.2M | |
Foreign Exchange Rate Adjustment | $348K | $1.7M | -$1.2M | $1.8M | $388K | |
Additions / Reductions | $41.9M | -$21.3M | -$20.9M | -$37.4M | -$305.1M | |
Ending Cash (CF) | $151.3M | $369.7M | $329.1M | $619M | $190.5M | |
Levered Free Cash Flow | -$16.3M | -$18.3M | -$22.7M | -$39.6M | -$80.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.